GGrantIndex
Sort

51,593 grants matching hepatitis

Immunotherapy of low grade lymphoid malignancies

$1,371,922
Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2024 · HL

Botanical Dietary Supplements for Women's Health

$1,371,817
Richard B Van Breemen · University Of Illinois At Chicago · P50 · FY2011 · AT

Multidisciplinary Studies of Hematopoietic Malignancies

$1,371,718
Lindsay Morton · Division Of Cancer Epidemiology And Genetics · ZIA · FY2011 · CA

Cornell Clinical Trials Unit

$1,371,244
Roy M Gulick · Weill Medical Coll Of Cornell Univ · U01 · FY2010 · AI

Stellenbosch University Clinical Trials Unit (SUN-CTU)

$1,369,582
Mark Fredric Cotton · Stellenbosch University · UM1 · FY2014 · AI

Adult-to-Adult Living Donor Liver Transplantation Study Data Coordinating Center

$1,368,463
Robert M Merion · University Of Michigan At Ann Arbor · U01 · FY2012 · DK

Pre-clinical Vaccine and Antibody Development for Coronavirus Disease 2019 (COVID-19)

$1,368,169
Wing Pui Kong · National Institute Of Allergy And Infectious Diseases · ZIC · FY2024 · AI

The Southeastern Cooperative Hepatitis C Research Group

$1,367,930
University Of Texas Medical Br Galveston · U19 · FY2005 · AI

HAWAII ACTU - ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM

$1,367,841
University Of Hawaii At Manoa · U01 · FY2002 · AI

Molecular mechanisms of liver injury, repair, and immunity

$1,367,062
Bin Gao · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2023 · AA

Pathogenesis and Novel Therapeutic Targets of Fatty Liver Disease and Cancer

$1,367,061
Bin Gao · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2023 · AA

Molecular Mediators and Regulators of Glucocorticoid Actions

$1,366,941
Tomoshige Kino · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2010 · HD

MSM and Substances Cohort at UCLA Linking Infections Noting Effects (MASCULINE)

$1,366,414
Pamina Mae Gorbach · University Of California Los Angeles · U01 · FY2014 · DA

Novel Cannabinoid Receptor Modulators

$1,365,662
Malliga Iyer · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2025 · AA

Reducing Plasma Cholesterol and Atherosclerosis Using miR-30c Analog C2

$1,364,153
M Mahmood Hussain · New York University D/B/A Nyu Long Island School Of Medicine · R01 · FY2025 · HL

San Francisco Bay Clinical Trials Unit

$1,364,094
Susan Buchbinder · Public Health Foundation Enterprises · UM1 · FY2015 · AI

Structural Biology Of Virus Assembly

$1,363,634
Alasdair C. Steven · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2013 · AR

1/2 Sickel Cell Disease Treatment with Arginine Therapy (STArT Trial)

$1,362,205
Claudia R Morris · Emory University · UH3 · FY2024 · HL

Hepatitis B Research Network (HBRN): Natural History and Treatment Studies

$1,361,363
Mandana Khalili · University Of California, San Francisco · U01 · FY2018 · DK

Mechanism of oxidative/nitrosative stress and inflammation-induced tissue injury

$1,361,114
Pal Pacher · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2012 · AA

Alcohol Research Consortium in HIV: Ending the HIV Epidemic through interventions and Epidemiology at the intersection of the alcohol and HIV care Continua

$1,360,895
Mary E McCaul · Johns Hopkins University · P01 · FY2023 · AA

Neurobiology of Addiction

$1,360,000
George Koob · National Institute On Drug Abuse · ZIA · FY2020 · DA

Task A10: Efficacy Testing of Therapeutics for Hepatitis C

$1,359,759
Norman Kneteman · Kmt Hepatech Inc · N01 · FY2014 · AI

A Randomized Controlled Trial of Prophylaxis with Direct-acting Antivirals for Kidney Transplantation from Hepatitis C virus-infected donor to Uninfected Recipients (PREVENT-HCV)

$1,359,557
Christine Marie Durand · Johns Hopkins University · U01 · FY2025 · AI

The Ohio State University AIDS Clinical Trials Unit

$1,359,474
Susan L Koletar · Ohio State University · U01 · FY2009 · AI